Patients with primary or secondary IgG subclass deficiencies suffer fr
om infections due to encapsulated microorganisms such as H influenzae
and pneumococci. In addition to relapsing infections, some patients wi
th primary subclass deficiencies may have autoimmune disorders. The be
st characterized defect is IgG2 deficiency, either isolated or combine
d with IgC4 deficiency. It is frequently associated with IgA deficienc
y or with ataxia teleangiectasia. IgG1 deficiency occurs mostly in com
bination with disturbances of other immunoglobulin isotypes, and proba
bly represents a form of common variable immune deficiency. Decreased
IgG3 levels were reported in association with lung dysfunction and vir
al diseases. Except in IgG1 deficiency, total IgG serum levels in prim
ary as well as secondary IgG subclass deficiency states may be normal
or even increased. It is assumed that IgG subclass deficiencies repres
ent an indicator of more basic immunologic abnormalities. There is evi
dence that antibody defects correlate better with the clinical symptom
s than the total serum IgG subclass concentrations. In patients with s
evere recurrent infections and IgG subclass deficiency, intravenous im
munoglobulin treatment at dosages of 0.3 to 0.4 g/kg body weight every
3-4 weeks is indicated.